Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
2
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
accent therapeutics
acute migrane
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
bain capital
bausch health
bioeurope
biogen
biomarin pharmaceutical
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brainvectis
breast cancer
c. greg guyer
cancer
cara therapeutics
clinical trials
deerfield management
desmoid tumor
detroit blog main
detroit top stories
dihydroergotamine
dihydroergotamine mesylate
drug development
drug discovery
esperion
europe blog main
What
activity
2
×
ipo
approvals
bio
biogen
biotech
clamped
companies
covid
days
delays
developing
dog
drug
economic
fast
fda
firm
hasn’t
including
ipos
isn’t
leading
line
lot
medicines
migraine
new
oric’s
pfizer
place
prep
roundup
satsuma
securing
showing
slowed
spinout
spread
springworks
Language
unset
Current search:
activity
×
" national blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs